{"@context":"https://schema.org","@graph":[{"@id":"https://thehippiescientist.net/compounds/bpc-157/#entity","@type":["ChemicalSubstance","MolecularEntity"],"additionalProperty":[{"@type":"PropertyValue","propertyID":"evidence tier","value":"Preliminary evidence"},{"@type":"PropertyValue","propertyID":"evidence label","value":"D"},{"@type":"PropertyValue","propertyID":"AI entity completeness score","value":34}],"category":"Synthetic peptide (gastric-derived sequence)","description":"BPC-157 is a synthetic 15-amino-acid peptide studied mainly in animal models for tissue repair and inflammation. FDA identified five small human clinical studies in its 2026 review, but the evidence is short-duration, heterogeneous, and insufficient to establish clinical efficacy or long-term safety; BPC-157 is not FDA-approved.","identifier":[{"@type":"PropertyValue","propertyID":"THS entity id","value":"ths:compound:bpc-157"},{"@type":"PropertyValue","propertyID":"THS slug","value":"bpc-157"}],"mentions":[{"@id":"https://thehippiescientist.net/compounds/tb-500/#entity","@type":["ChemicalSubstance","Thing"],"additionalProperty":[{"@type":"PropertyValue","propertyID":"relationship type","value":"related-to"}],"name":"TB 500","url":"https://thehippiescientist.net/compounds/tb-500/"}],"name":"BPC-157","subjectOf":{"@id":"https://thehippiescientist.net/compounds/bpc-157/#evidence-data"},"url":"https://thehippiescientist.net/compounds/bpc-157/"},{"@id":"https://thehippiescientist.net/compounds/bpc-157/#evidence-data","@type":"Article","about":{"@id":"https://thehippiescientist.net/compounds/bpc-157/#entity"},"author":{"@type":"Person","name":"Willie B. Randolph III","url":"https://thehippiescientist.net/info/author/","@id":"https://thehippiescientist.net/info/author/#person","affiliation":{"@id":"https://thehippiescientist.net/#organization"}},"dateModified":"2026-08-26","dateReviewed":"2026-08-26","description":"BPC-157 is a synthetic 15-amino-acid peptide studied mainly in animal models for tissue repair and inflammation. FDA identified five small human clinical studies in its 2026 review, but the evidence is short-duration, heterogeneous, and insufficient to establish clinical efficacy or long-term safety; BPC-157 is not FDA-approved.","headline":"BPC-157 evidence, safety, and entity data","mainEntity":{"@id":"https://thehippiescientist.net/compounds/bpc-157/#entity"},"mentions":[{"@id":"https://thehippiescientist.net/compounds/tb-500/#entity","@type":["ChemicalSubstance","Thing"],"additionalProperty":[{"@type":"PropertyValue","propertyID":"relationship type","value":"related-to"}],"name":"TB 500","url":"https://thehippiescientist.net/compounds/tb-500/"}],"publisher":{"@type":"Organization","name":"The Hippie Scientist","url":"https://thehippiescientist.net","@id":"https://thehippiescientist.net/#organization"},"url":"https://thehippiescientist.net/compounds/bpc-157/"}]}